Search Browse Earnings

Bionano Genomics, Inc. — SlamSEC

Bionano Genomics, Inc.

Nasdaq:BNGO

Laboratory Analytical Instruments·SAN DIEGO, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$36.1M

+29.9% YoY

FY 2024

Adj. EBITDA

-$201.5M

-558.0% margin

FY 2024

Net Income

-$232.5M

-643.7% margin

FY 2024

EPS (Diluted)

-$408.60

FY 2024

Stock Price

$1.15

+2.2%

2026-03-11

52W Range

$1.06 – $5.50

P/E Ratio

-0.0x

Market Cap

$11.7M

Cash

$17.9M

FY 2024

Total Debt

$16.3M

FY 2021

Net Cash

$1.6M

FY 2021

Enterprise Value

$10.1M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-0.1x

Employees

—